|Chicago racing newsletter sign-up
Horse slaughter in Illinois
Racing Medication and Testing Consortium
|Racing Medication and Testing Consortium (6/29/06)
Scot Waterman, executive director, RMTC, (859) 422-2675
RMTC BOARD FINALIZES PLAN TO ESTABLISH MODEL POLICIES FOR WITHDRAWAL TIMES FOR THERAPEUTIC MEDICATIONS
During its meeting on Tuesday, June 27, at the Dallas/Fort Worth Airport, the Board of Directors of the Racing Medication and Testing Consortium (RMTC) finalized a two-part plan to establish model policies for withdrawal times for therapeutic medications in racehorses.
In part one, the RMTC will compile existing withdrawal guidelines for 50 therapeutic medications identified by the American Association of Equine Practitioners (AAEP) by surveying state racing commissions and utilizing veterinary expertise in each state.
“We will continue our survey of current withdrawal times in each state with the goal of producing guidelines that can be published and placed on the RMTC website so horsemen will have a better idea of therapeutics allowed in individual jurisdictions,” said RMTC Chairman Dan Fick.
In part two of the plan, the RMTC will prepare a request for proposals on therapeutic medications that need additional research to better define their withdrawal times. The research process will be fast-tracked in order to obtain, as quickly as possible, the additional data needed.
The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred and American Quarter Horse racing. The organization works to develop, promote and coordinate, at the national level, policies, research, and educational programs that seek to ensure the fairness and integrity of racing, the health and welfare of racehorses and participants, and protect the interests of the betting public.
To date, the Model Rule that covers aspects of medication and testing, including race-day medications, penalties, testing and prohibited practices, has been adopted or is in the process of being adopted in 30 of 38 pari-mutuel horse racing jurisdictions.
The use of anabolic steroids in racehorses and in sales horses currently is a significant issue in the industry. At the RMTC Board meeting, RMTC Secretary Dr. Rick Arthur presented a report on the subject from the group’s Subcommittee on Anabolic Steroids. Following a complete review of existing research and of rules from international racing jurisdictions, the subcommittee plans to deliver its preliminary recommendations for a Model Policy on anabolic steroids at the next RMTC Board meeting in November.
At the June 26 meeting, the RMTC Board also:
The next RMTC Board meeting is tentatively scheduled to be held in Louisville, Ky., on November 2, two days before the Breeders’ Cup World Championships at Churchill Downs.
In other RMTC news:
For additional information, visit the RMTC website at www.rmtcnet.com.
News Updates |
Resources | Links | Marketplace | Gallery | Advertising | Contact Us
Copyright © 2000-2013 Chicago Barn to Wire. All rights reserved.